Controversies, new risk factors and the neuroendocrine approach to fibromyalgia: can therapeutic progress be made at last?
Shipton, E.
New Zealand Medical Journal 116(1174): U439
2003
ISSN/ISBN: 1175-8716 PMID: 12766785 Document Number: 561302
Document emailed within 1 workday
Related Documents
Cerrotta, A.; Lozza, L.; Kenda, R.; Gardani, G.; Galante, E.; Zucali, R. 1997: Current controversies in the therapeutic approach to early breast cancer in the elderly Rays 22(1 Suppl): 66-68Horiuchi, M. 2016: The Protective Arm of Renin Angiotensin System; Recent Research Progress and Expectation for new Therapeutic Approach Nihon Rinsho. Japanese Journal of Clinical Medicine 74(9): 1583-1589
Jung, J.H.; Choi, K.D.; Koh, Y.W.; Park, Y.S.; Jung, H.-Y.; Lee, G.H.; Song, H.J.; Kim, D.H.; Choi, K.-S.; Lee, J.H.; Ahn, J.Y.; Kim, M.-Y.; Bae, S.E.; Kim, J.-H. 2015: Risk factors of lymph node metastasis in patients with gastric neuroendocrine tumor with normal serum gastrin level Hepato-Gastroenterology 62(137): 207-213
Huamei, Y.; Yu, Z.; Xin, Z.; Ga, L.; Qianming, C. 2015: Research progress on the risk factors of geographic tongue Hua Xi Kou Qiang Yi Xue Za Zhi 33(1): 93-97
Marmont, A.M. 1987: Allogeneic bone marrow transplantation for chronic granulocytic leukaemia: progress and controversies Haematologica 72(4): 285-289
Wernli, M.; Fehr, H. 1984: Risk factors in diagnostic and therapeutic use of ERCP Schweizerische Rundschau für Medizin Praxis 73(42): 1277-1278
Seirafi, M.; Iten, A.; Hadengue, A. 2007: Acetaminophen: hepatotoxicity at therapeutic doses and risk factors Revue Medicale Suisse 3(129): 2345-2349
Chadarevian, R.; Bruckert, E.; Turpin, G. 1998: Lipids/hemostasis interactions. a new approach to cardiovascular risk factors Presse Medicale 27(28): 1437-1439
Diquet, B.; Lainé-Cessac, P. 2005: The search for risk factors and the therapeutic consequences. Drug interactions La Revue du Praticien 55(5): 541-545
Veltri, A.; Scarpellini, P.; Piccinni, A.; Conversano, C.; Giacomelli, C.; Bombardieri, S.; Bazzichi, L.; Dell'Osso, L. 2012: Methodological approach to depressive symptoms in fibromyalgia patients Clinical and Experimental Rheumatology 30(6 Suppl 74: 136-142
Cohen, R.L.; Alfonso, Y.Natalia.; Adam, T.; Kuruvilla, S.; Schweitzer, J.; Bishai, D. 2014: Country progress towards the Millennium Development Goals: adjusting for socioeconomic factors reveals greater progress and new challenges Globalization and Health 10: 67
Cohen, R.L.; Alfonso, Y.Natalia.; Adam, T.; Kuruvilla, S.; Schweitzer, J.; Bishai, D. 2014: Country progress towards the Millennium Development Goals: adjusting for socioeconomic factors reveals greater progress and new challenges Globalization and Health 10: 67
Vrhovski, D.; Mestrić, Z.; Subić, N.; Surina, B.; Kranjcević, S. 1985: Established risk factors and complementary risk factors as additional parameters in evaluating the risk of cardiovascular diseases Lijecnicki Vjesnik 107(11-12): 481-484
Zhao, R.-h.; Zhu, Y.-b. 2009: Observation on therapeutic effect of herb-partitioned moxibustion on fibromyalgia syndrome Zhongguo Zhen Jiu 29(3): 200-202
Kasai, T.; Takeda, B.; Takamizawa, H. 1984: Studies on the early diagnosis of endometrial carcinoma. Analysis of risk factors and cytological approach Nihon Sanka Fujinka Gakkai Zasshi 36(6): 865-874
Montillo, M.; Hamblin, T.; Hallek, M.; Montserrat, E.; Morra, E. 2005: Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies Haematologica 90(3): 391-399
Gomutbutra, T. 2005: Risk factors and techniques affecting surgical outcome of therapeutic endoscopic retrograde cholangiopancreatography difficulties Journal of the Medical Association of Thailand 88(8): 1103-1109
Faurschou, M.; Starklint, H.; Halberg, P.; Jacobsen, Søren. 2006: Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure Journal of Rheumatology 33(8): 1563-1569
Scheen, Aé.J.; Paquot, N. 2010: Multirisk approach of the type 2 diabetic patient: controversies surrounding target values after the ACCORD trial Revue medicale suisse 6(260): 1582-1587
Smythe, H. 2006: The Symptom Intensity Scale, fibromyalgia, and the meaning of fibromyalgia-like symptoms. a review Journal of Rheumatology 33(11): 2113-2114